Facts and figures

General information

• Irish headquarters: 3/4 Upper Pembroke Street, Dublin 2

• Global headquarters: Bagsværd, Denmark

• Irish workforce: 21 employees (December 2008)

• Global workforce: More than 27,068 employees (December 2008).

Product areas

• Diabetes care
• Hormone replacement therapy (HRT)
• Haemostasis management (NovoSeven^®)
• Growth hormone therapy

Global financial information
Sales: 45,553 million Danish kroner

Sales by business segment*
- Diabetes care 33,356

- Biopharmaceuticals 12,197

Turnover by region*
- Europe 17,219

- Japan & Oceania 4,755

- North America 15,154

- International Operations 8,425

* million Danish kroner, full year 2008

_{Back to top
IC09010}